Accurately quantifying CRISPR editing efficiency is critical for successful gene editing in research and therapeutic development.
This article provides a comprehensive resource for researchers and drug development professionals utilizing CRISPR in G0 zebrafish.
This article provides a comprehensive overview of CRISPR/dCas9-based epigenome editing in zebrafish embryos, a rapidly advancing field that merges the genetic tractability of zebrafish with precision epigenetic tools.
This article provides a comprehensive guide for researchers and drug development professionals on evaluating and mitigating CRISPR-Cas9 off-target effects in zebrafish models.
This article provides a comprehensive overview of CRISPR activation (CRISPRa) technology using catalytically dead Cas9 (dCas9) for targeted transcriptional upregulation in the zebrafish model.
This article provides a complete roadmap for researchers, scientists, and drug development professionals seeking to master sgRNA production via in vitro transcription (IVT).
This article provides a comprehensive analysis of the ethical considerations in zebrafish genome editing for researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on designing single-guide RNAs (sgRNAs) for effective CRISPR applications in zebrafish.
This comprehensive review explores the mechanisms and applications of double-strand break repair pathways—Non-Homologous End Joining (NHEJ) and Homology-Directed Repair (HDR)—in the zebrafish model.
This article synthesizes the latest advances in applying CRISPR technologies to study the Maternal-to-Zygotic Transition (MZT), a fundamental reprogramming event in early embryonic development.